Literature DB >> 19218785

Anatomy of the ligamentum venosum arantii and its contribution to the left hepatic vein and common trunk control. A study on cadaveric livers.

Raja Dahmane1, Abdelwaheb Morjane, Dean Ravnik, Marija Hribernik.   

Abstract

BACKGROUND: The control of the left hepatic vein (LHV) and the common trunk of the middle hepatic vein (MHV) and LHV (CT) is considered difficult during liver resection and could be improved by detailed knowledge on the ligamentum venosum Arantii (LV). AIM: The aim of this study was to describe the LV and its connections to the LHV and the CT and to present surgical relevance of the obtained data.
MATERIAL AND METHODS: During autopsy of 50 cadavers of both sexes, the LV was exposed, measured and then dissected, simulating a surgical maneuver to facilitate the approach to the LHV and CT. The extrahepatic parts of the LHV, MHV and CT were measured.
RESULTS: The LV was 52-70 mm long and 5-8 mm thick. It had a fibrotic structure and was not patent in 96% of the cases. The extrahepatic part of the LHV measured 3-19 mm, that of the MHV 3-18 mm and that of the CT 4-15 mm.
CONCLUSION: LV dissection facilitated extraparenchymatous clamping of the hepatic veins: the extrahepatic parts of the LHV and CT measured > 3 mm in 86 and 84% of the cases, respectively. 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19218785     DOI: 10.1159/000202979

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  2 in total

1.  Termination of the ligamentum venosum and the topographic relationship between the left portal vein, left hepatic artery, and ligamentum venosum in the fissures for the ligamentum teres and ligamentum venosum.

Authors:  Mi-Sun Hur; Ho-Jeong Kim; Kyu-Seok Lee
Journal:  Surg Radiol Anat       Date:  2014-09-11       Impact factor: 1.246

2.  Usefulness of the Ligamentum Venosum as an Anatomical Landmark for Safe Laparoscopic Left Hepatectomy (How I Do It).

Authors:  Ji Hoon Kim
Journal:  J Gastrointest Surg       Date:  2018-04-02       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.